Business conflict and global politics: The pharmaceutical industry and the global protection of intellectual property rights

Roemer-Mahler, Anne

doi:10.1080/09692290.2011.645848

Cited by 33 publications

(26 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…One of our interviewees indicated that ‘ the main driver of the tobacco market now is regulation, by far’ and that in this context a multilateral challenge by TTCs to national legislation that risked spillover to other markets, is a logical step (Author interview, May 2016). As such, our analysis provides new insights into MNE lobbying in international trade disputes over domestic regulations and complement the emerging scholarship on the political economy of international regulation and “regulatory capture” (De Bièvre et al 2014; Lawton et al 2009; Roemer-Mahler 2013; Woll and Artigas, 2007; Young 2012; Young 2016). The findings presented here also confirm earlier research (Eckhardt and de Bievre 2015), which indicates that in order to undertake transnational CPA, companies need to be facing a real and existential threat, that they need to be highly globalized, concentrated, well- organized and endowed.…”

Section: Discussionmentioning

confidence: 62%

“…Such challenges have become increasingly common in the global economy and, despite growing scholarly attention (De Bièvre et al 2014; Lawton et al 2009; Roemer-Mahler 2013; Young 2012; Young 2016), we know surprisingly little about the effect of this shift in lobbying by economic actors. In this endeavor, we not only aim to provide insights into firm lobbying on trade issues, but also on transnational lobbying more generally.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging

Curran

Eckhardt

2017

Review of International Political Economy

View full text Add to dashboard Cite

In 2012 Australia became the first country in the world to introduce plain tobacco packaging in an effort to reduce tobacco consumption. This move was vehemently opposed by the tobacco industry, which challenged it on several levels: nationally, bilaterally and multilaterally at the World Trade Organization (WTO). The political behavior of the tobacco companies in this case is puzzling both in terms of scale, operating at multiple levels at the same time and in terms of the countries mobilized in their defence. WTO litigation is typically the result of Multi National Enterprises (MNEs) lobbying their own government, but here third countries were mobilized. Lobbying in third country contexts, with the objective of accessing multilateral dispute settlement systems, has been little studied. We thus know very little about the driving factors behind such activities, how target governments are selected and what lobbying strategies are used. This paper draws on emerging research on transnational lobbying and a case study of the PP case to explore these issues in detail and, by doing so, aims to further our theoretical understanding of the political economy of international trade in the context of increasing regime complexity and globalization of production.

show abstract

Section: Discussionmentioning

confidence: 62%

Section: Introductionmentioning

confidence: 99%

Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging

Curran

Eckhardt

2017

Review of International Political Economy

View full text Add to dashboard Cite

show abstract

“…Ebenfalls ist belegt, wie die Normsetzung im Bereich von geistigen Eigentumsrechten erst von einer koordinierten Allianz transnational tätiger Pharma-Firmen angestoßen wurde (Sell und Prakash 2004;Roemer-Mahler 2011) Wenn man die Auseinandersetzung im Zentralen Patent-und Handelsgericht und im Gesundheitsministerium und die daraus hervorgegangenen global gültigen Regulierungen im Patentbereich im Licht einer neo-poulantzistischen Staatstheorie betrachtet, dann stellt Thailand weder einen Fall von Erosion noch von Erstarkung von nationalstaatlichen Staatsapparaten dar, sondern eine Entwicklung von staatlichen Institutionen auf der nationalen Ebene unter Globalisierungsbedingungen. Tatsächlich fand die Etablierung dieses Systems in einer engen Verzahnung mit Globalisierungsprozessen statt, die erzwangen, dass die Regulierungskompetenz nicht nur nach innen (d. h. innerhalb des thailändischen Staates), sondern auch nach außen, d. h. auf globaler Ebene durchgesetzt werden musste.…”

Section: Fazitunclassified

Die großen Schwellenländer

Nölke¹,

May²,

Claar³

2014

View full text Add to dashboard Cite

Die Deutsche Nationalbibliothek verzeichnet diese Publikation in der Deutschen Nationalbibliografi e; detaillierte bibliografi sche Daten sind im Internet über http://dnb.d-nb.de abrufb ar. Springer VS © Springer Fachmedien Wiesbaden 2014Das Werk einschließlich aller seiner Teile ist urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung des Verlags. Das gilt insbesondere für Vervielfältigungen, Bearbeitungen, Übersetzungen, Mikroverfi lmungen und die Einspeicherung und Verarbeitung in elektronischen Systemen.Die Wiedergabe von Gebrauchsnamen, Handelsnamen, Warenbezeichnungen usw. in diesem Werk berechtigt auch ohne besondere Kennzeichnung nicht zu der Annahme, dass solche Namen im Sinne der Warenzeichen-und Markenschutz-Gesetzgebung als frei zu betrachten wären und daher von jedermann benutzt werden dürft en.

show abstract

“…from India). Pharmaceutical companies also increasingly resort to this form of protection (Roemer-Mahler 2012). In a global context, data exclusivity is still a highly contested issue.…”

Section: Craig Venter's Model Of Proprietary Sciencementioning

confidence: 99%

Synthetic biology, patenting, health and global justice

Belt

2012

Syst Synth Biol

View full text Add to dashboard Cite

The legal and moral issues that synthetic biology (SB) and its medical applications are likely to raise with regard to intellectual property (IP) and patenting are best approached through the lens of a theoretical framework highlighting the ''co-construction'' or ''co-evolution'' of patent law and technology. The current situation is characterized by a major contest between the so-called IP frame and the access-to-knowledge frame. In SB this contest is found in the contrasting approaches of Craig Venter's chassis school and the BioBricks school. The stakes in this contest are high as issues of global health and global justice are implied. Patents are not simply to be seen as neutral incentives, but must also be judged on their effects for access to essential medicines, a more balanced pattern of innovation and the widest possible social participation in innovative activity. We need moral imagination to design new institutional systems and new ways of practising SB that meet the new demands of global justice.

show abstract

Business conflict and global politics: The pharmaceutical industry and the global protection of intellectual property rights

Cited by 33 publications

References 39 publications

Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging

Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging

Die großen Schwellenländer

Synthetic biology, patenting, health and global justice

Contact Info

Product

Resources

About